No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
404 |
4. Check minimum number of eventsNone |
404 |
5. Include endpointsNone |
404 |
6. Filter based on genotype QC (FinnGen only) |
404 |
Control definitions (FinnGen only)
- Control exclude
- D3_HAEMOLYTICANAEMIA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D59
- Name in latin
- Aliae anaemiae autoimmunes haemolyticae
Similar endpoints
↥List of similar endpoints to
Other autoimmune haemolytic anaemias
based on the number of shared cases.
Similar with more cases:
- Acquired haemolytic anaemia
- Haemolytic anaemias
- Anaemias
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Autoimmune diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3078 | 1652 | 1390 |
| Only index persons | 2344 | 1276 | 1068 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.05 | 0.04 |
| Only index persons | 0.04 | 0.05 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 68.37 | 69.80 | 66.65 |
| Only index persons | 67.43 | 68.54 | 66.11 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 404 | 207 | 197 |
| Unadjusted period prevalence (%) | 0.08 | 0.07 | 0.09 |
| Median age at first event (years) | 63.83 | 60.36 | 67.47 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 363
- Matched controls
- 3629
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
+∞
323.0
344
*
XW000
NOMESCO Finland
Bone marrow biopsy
25.1
78.2
113
64
D59.9
ICD-10 Finland
Acquired haemolytic anaemia, unspecified
+∞
67.9
63
*
D64.9
ICD-10 Finland
Anaemia, unspecified
9.8
63.8
147
235
H02AB06
ATC
prednisolone; systemic
5.5
48.0
271
1267
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
14.8
45.5
79
67
WW500
NOMESCO Finland
Blood transfusion
13.0
40.4
74
70
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
42.3
38.9
48
13
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.9
32.6
198
851
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
42.2
30.9
38
10
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
19.1
30.7
47
28
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
26.3
29.0
40
17
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.8
28.8
111
305
ZX120
NOMESCO Finland
Intravenous
5.4
28.3
94
219
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
46.7
28.3
34
8
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
17.4
20.5
32
20
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.8
19.9
59
117
M04AA01
ATC
allopurinol; systemic
3.8
19.0
92
300
2830A
ICD-9 Finland
Acquired haemolytic anaemias, Autoimmune haemolytic anaemias[ANAEMIA HAEMOLYTICA AUTOIMMUNISATORIA PRIMARIA]
+∞
18.9
18
*
JN4BD
NOMESCO Finland
Extensive body CT
4.0
18.4
80
237
H02AB07
ATC
prednisone; oral
3.6
18.4
94
320
L03AA02
ATC
filgrastim; parenteral
9.6
17.1
35
40
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
94.5
16.7
18
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
12.0
16.6
30
27
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
15.9
207
1255
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
15.6
128
597
1XC02
NOMESCO Finland
NA
30.1
15.4
20
7
D59.8
ICD-10 Finland
Other acquired haemolytic anaemias
+∞
14.7
14
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.3
13.7
75
264
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
13.5
103
452
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
12.8
136
718
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
12.6
12
*
D59.0
ICD-10 Finland
Drug-induced autoimmune haemolytic anaemia
+∞
12.6
12
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
12.6
12
*
L04AX01
ATC
azathioprine; systemic
5.3
12.3
38
79
A02BC02
ATC
pantoprazole; systemic
2.3
12.3
256
1848
L01AA02
ATC
chlorambucil; oral
48.4
12.0
14
*
L01AA01
ATC
cyclophosphamide; systemic
17.1
11.8
18
11
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
19.7
11.7
17
9
R50.9
ICD-10 Finland
Fever, unspecified
2.9
11.6
79
319
28390
ICD-8 Finland
Acquired haemolytic anaemias, Autoimmunisatoria primaria
+∞
11.5
11
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.8
11.4
50
148
A04AA01
ATC
ondansetron; systemic, rectal
4.2
11.2
43
113
M05BA04
ATC
alendronic acid; oral
3.4
11.1
55
179
6BA02
NOMESCO Finland
NA
44.8
11.0
13
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.1
10.8
42
111
H02AB09
ATC
hydrocortisone; systemic
8.4
10.8
23
29
L03AA13
ATC
pegfilgrastim; parenteral
6.5
10.7
27
44
J05AB11
ATC
valaciclovir; oral
2.9
9.8
63
246
JN4AD
NOMESCO Finland
Body CT examination
3.5
9.5
45
142
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
6.2
9.2
24
41
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
24.7
9.0
12
5
J01MA12
ATC
levofloxacin; systemic
2.4
8.8
86
422
UJF32
NOMESCO Finland
Coloscopy
2.1
8.7
113
631
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
51.3
8.7
10
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.2
8.7
26
53
JMA10
NOMESCO Finland
Transabdominal total splenectomy
20.6
8.5
12
6
L01XX52
ATC
venetoclax; oral
92.1
8.4
9
*
D59.4
ICD-10 Finland
Other nonautoimmune haemolytic anaemias
+∞
8.4
8
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.9
8.3
33
90
PJA10
NOMESCO Finland
Exploration of lymph nodes
14.9
8.3
13
9
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
34.2
8.1
10
*
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.1
8.1
21
36
D64.8
ICD-10 Finland
Other specified anaemias
8.0
8.0
17
22
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
7.9
88
457
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.5
7.9
27
64
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
15.5
7.8
12
8
L01BB05
ATC
fludarabine; systemic
46.0
7.7
9
*
399
Kela drug reimbursment
Venetoclax
46.0
7.7
9
*
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
8.3
7.7
16
20
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
8.3
7.7
16
20
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
6.0
7.6
20
35
B03BA03
ATC
hydroxocobalamin; parenteral
3.2
7.5
38
127
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.9
7.5
23
49
6753
FHL
Transabdominal splenectomy
81.7
7.4
8
*
2830X
ICD-9 Finland
Acquired haemolytic anaemias, Autoimmune haemolytic anaemias[ANAEMIA HAEMOLYTICA AUTOIMMUNISATORIA NUD]
+∞
7.3
7
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.9
7.3
29
80
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
30.7
7.2
9
*
A41.9
ICD-10 Finland
Sepsis, unspecified
4.2
7.1
26
66
GD1AD
NOMESCO Finland
Thorax CT examination
4.2
7.1
26
66
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
9.1
7.1
14
16
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
7.2
7.1
16
23
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.8
7.0
22
48
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.0
7.0
39
138
TGC00
NOMESCO Finland
Bronchial lavation
5.2
6.9
20
40
1AA09
NOMESCO Finland
NA
40.8
6.8
8
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
40.8
6.8
8
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
23.0
6.7
9
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.3
6.6
32
104
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.2
6.5
32
105
ZX112
NOMESCO Finland
Subcutaneous
5.1
6.5
19
39
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.3
6.4
60
287
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
5.7
6.4
17
31
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.3
6.3
22
54
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
6.3
6
*
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
+∞
6.3
6
*
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
6.3
6
*
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
6.3
6
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
27.2
6.3
8
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
27.2
6.3
8
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.0
6.2
23
60
J01MA14
ATC
moxifloxacin; systemic
2.8
6.2
39
149
B82
ICPC
Anaemia other/unspecified
5.1
6.1
18
37
WW200
NOMESCO Finland
Immunization
4.3
6.1
21
51
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
6.1
90
522
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
214
90
49.43
322.19
6.1
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
243
161
36.36
304.59
9.1
1.5
g/l
0.9
1.6
11.50
189
142
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
282
396
21.27
222.66
20.1
3.6
u/l
305.8
245.1
5.45
273
375
(3027945) Reticulocytes/100 erythrocytes in Blood
280
422
19.36
208.36
19.2
2.4
%
3.3
1.8
21.04
265
378
(3023520) Reticulocytes [#/volume] in Blood
243
314
17.91
200.11
19.7
2.5
e9/l
119.0
68.9
18.85
206
239
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
96
17
73.76
174.85
5.3
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
96
17
73.76
174.85
5.3
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
87
22
50.12
146.47
2.9
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
176
238
12.33
134.51
5.3
2.5
g/l
10.4
10.4
0.00
166
217
(3028026) IgM [Mass/volume] in Serum or Plasma
157
200
12.20
124.62
2.9
1.6
g/l
1.9
1.5
0.62
141
179
(3042111) Morphology [Interpretation] in Bone marrow Narrative
99
67
19.25
115.85
1.5
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
72
32
27.16
101.02
1.3
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
92
76
15.38
95.87
1.8
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
75
42
21.70
95.49
1.4
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
83
58
17.75
94.86
6.8
6.7
iu/ml
889.4
147.1
—
25
8
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
102
106
12.53
91.81
2.4
3.8
ratio
71.4
2.7
—
7
11
(3034860) Kappa light chains.free [Mass/volume] in Serum
103
109
12.34
91.56
2.5
3.9
mg/l
62.6
124.5
0.47
87
83
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
103
109
12.34
91.56
2.4
4.0
mg/l
25.4
40.3
0.81
87
84
(40760888) Immunoglobulin light chains.free panel - Serum
88
79
13.96
86.89
2.3
4.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
137
243
8.02
79.97
3.2
2.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
148
291
7.45
78.25
3.2
3.1
g/l
66.9
66.2
0.35
141
260
(3021879) Hepatitis B virus core Ab [Presence] in Serum
120
194
8.38
75.85
1.4
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
146
307
6.88
71.64
1.6
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
181
509
5.63
63.86
3.3
2.3
g/l
2.1
2.3
4.22
170
473
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
152
370
5.98
63.07
1.6
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
189
561
5.45
62.34
3.6
2.3
umol/l
15.8
12.8
3.91
174
517
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
173
492
5.40
59.65
3.3
2.3
%
31.2
21.8
6.26
146
422
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
60
53
13.12
59.13
1.2
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
90
138
8.10
58.76
2.9
2.1
g/l
5.7
7.5
13.66
66
106
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
90
138
8.10
58.76
2.9
2.1
g/l
3.3
3.8
1.68
65
100
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
90
138
8.10
58.76
2.9
2.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
52
37
15.98
58.08
1.2
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
58
50
13.38
58.00
1.5
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
86
129
8.20
57.17
3.0
2.2
g/l
2.8
3.2
3.19
65
101
(42870588) Differential panel, method unspecified - Blood
269
1119
5.20
57.06
15.9
5.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
149
390
5.47
56.22
5.5
3.1
umol/l
12.3
9.2
0.84
139
347
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
233
885
4.86
55.07
2.6
2.1
mg/l
4.2
3.1
6.06
211
761
(3018010) Neutrophils/100 leukocytes in Blood
320
1568
6.01
54.20
15.3
5.6
%
56.5
58.2
1.25
307
1464
(3022096) Basophils/100 leukocytes in Blood
312
1507
5.70
53.51
16.0
5.8
%
0.7
0.6
0.26
301
1398
(3019069) Monocytes/100 leukocytes in Blood
317
1556
5.82
53.14
17.6
6.0
%
8.7
8.8
0.10
307
1453
(3019198) Lymphocytes [#/volume] in Blood
331
1691
6.30
52.59
15.8
5.6
e9/l
2.6
1.9
1.24
304
1493
(3006315) Basophils [#/volume] in Blood
327
1656
6.11
52.45
15.6
5.5
e9/l
0.0
0.0
1.53
302
1432
(3006504) Eosinophils/100 leukocytes in Blood
315
1548
5.70
52.44
16.6
5.7
%
2.4
2.8
3.58
304
1438
(3002030) Lymphocytes/100 leukocytes in Blood
320
1593
5.85
52.40
16.9
5.8
%
29.6
26.7
2.63
308
1480
(3001604) Monocytes [#/volume] in Blood
326
1648
6.07
52.37
15.7
5.5
e9/l
0.6
0.6
0.23
301
1422
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
54
49
12.57
52.16
1.3
1.2
u/ml
314.6
301.5
0.06
29
21
(3013115) Eosinophils [#/volume] in Blood
330
1702
6.13
51.21
16.9
5.8
e9/l
0.2
0.2
2.00
306
1494
(3037522) Nuclear Ab [Titer] in Serum
143
389
5.14
51.00
1.7
1.3
titre
681.1
509.5
0.46
37
88
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
78
119
7.88
50.84
3.1
2.4
g/l
1.7
0.7
0.69
71
103
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
80
128
7.55
49.93
2.9
2.2
g/l
11.0
10.1
0.67
68
110
(3048929) Epstein Barr virus Ab [Presence] in Serum
65
85
8.92
48.17
1.3
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
111
260
5.51
46.81
7.8
4.0
%
0.7
0.4
0.89
51
68
(46235355) HIV 1 and 2 tests - Meaningful Use set
146
433
4.71
46.25
1.7
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
118
295
5.24
46.09
9.0
4.0
%
0.8
0.9
0.25
70
98
(3007164) IgA [Mass/volume] in Serum or Plasma
173
618
4.15
42.13
2.1
1.5
g/l
2.0
2.6
3.58
137
366
(3004809) Band form neutrophils/100 leukocytes in Blood
52
61
9.64
41.79
5.5
3.4
%
1.3
1.8
0.27
44
48
(3013650) Neutrophils [#/volume] in Blood by Automated count
335
1914
5.39
41.23
24.6
8.9
e9/l
4.4
4.2
0.14
311
1678
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
325
1819
5.02
41.00
21.3
6.2
umol/l
19.2
11.7
10.57
319
1720
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
28
11
27.28
40.23
1.3
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
106
272
4.93
39.67
9.2
4.1
%
0.0
0.2
1.13
67
85
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
43
44
10.82
38.07
1.4
1.3
u/ml
114.3
102.7
—
15
9
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
66
114
6.72
37.95
2.9
2.3
g/l
39.9
37.1
3.16
61
97
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
33
22
16.25
37.79
3.5
2.0
e6/l
408.9
484.6
0.25
17
11
(3001122) Ferritin [Mass/volume] in Serum or Plasma
268
1359
3.89
37.65
4.3
2.7
ug/l
572.4
125.3
3.86
254
1242
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
26
10
27.72
37.57
1.2
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
37
31
13.04
37.28
3.2
1.6
e9/l
1.0
0.9
0.18
19
17
(3000012) Reticulocyte production index
32
25
13.82
33.53
4.6
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
50
73
7.68
33.44
1.3
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
40
45
9.76
33.00
13.8
1.9
pg
34.0
32.9
0.95
40
45
(3025159) Blasts/100 leukocytes in Blood
95
258
4.51
32.67
9.1
4.2
%
0.0
1.3
0.55
55
74
(3003458) Phosphate [Moles/volume] in Serum or Plasma
130
446
3.82
32.36
7.6
5.4
mmol/l
1.1
1.0
1.46
124
406
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
260
1408
3.38
30.51
2.7
2.0
pmol/l
94.3
94.6
0.04
175
713
(3026493) Urate [Moles/volume] in Serum or Plasma
193
884
3.27
29.97
5.1
2.6
umol/l
354.3
9029.6
4.74
186
746
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
292
1710
3.55
29.80
13.2
6.9
mmol/l
1.2
1.2
0.15
260
1456
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
39
49
8.70
29.50
1.2
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
38
47
8.82
29.09
5.6
3.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
27
21
13.71
28.27
2.1
1.7
%
12.4
11.4
—
10
9
(3044640) Blood type and Crossmatch panel - Blood
214
1078
3.09
27.59
8.6
2.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
35
42
9.03
27.40
1.1
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
42
64
7.21
26.92
1.3
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
27
23
12.51
26.75
1.3
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
270
1570
3.17
26.60
11.0
6.1
mmol/l
1.2
1.2
0.12
255
1410
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
31
7
47.82
25.91
1.5
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
25
20
13.26
25.70
2.4
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
263
1530
3.06
25.45
12.2
4.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
45
79
6.28
25.19
1.7
1.7
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
33
41
8.68
25.11
4.8
2.5
%
56.0
58.9
0.18
24
28
(3024561) Albumin [Mass/volume] in Serum or Plasma
256
1477
3.00
24.97
8.0
4.6
g/l
34.5
35.2
1.31
248
1373
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
27
26
11.06
24.71
2.5
2.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
156
697
3.02
24.28
2.1
1.7
nmol/l
1448.1
1190.9
1.54
128
513
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
45
82
6.05
24.24
1.6
1.7
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
24
20
12.69
24.05
2.3
2.7
%
36.7
50.7
—
9
7
(3021960) Folate [Moles/volume] in Serum or Plasma
179
868
2.91
23.90
2.3
1.6
nmol/l
24.2
21.0
0.71
170
728
(4035726)
90
296
3.63
23.17
1.6
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
36
59
6.60
21.48
1.5
1.2
u/l
65.3
24.2
1.17
31
52
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
18
11
17.08
21.23
3.9
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
39
71
5.97
20.98
1.3
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
80
260
3.59
20.84
2.2
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
169
842
2.73
20.82
17.7
6.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
125
536
2.93
20.45
4.2
3.4
mmol/l
0.8
0.8
0.42
118
502
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
23
23
10.54
20.45
1.2
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
32
50
6.86
19.95
1.1
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
41
83
5.38
19.69
7.6
3.1
nmol/l
0.9
0.9
—
7
62
(21494814) CD8 cells/100 lymphocytes in Specimen
17
11
16.09
19.46
1.4
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
44
96
5.02
19.42
3.5
2.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
41
85
5.26
19.17
1.2
1.2
titre
104.3
46.3
—
7
8
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
129
586
2.76
18.72
2.8
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
161
818
2.61
18.65
7.4
2.4
—
—
—
0
0
(3017704) Immunofixation for Urine
21
21
10.49
18.63
1.1
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
34
61
5.99
18.53
1.7
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
185
1008
2.54
18.47
6.7
4.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
27
38
7.54
18.45
1.2
2.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
17
13
13.61
17.77
3.2
2.4
u/ml
1825.8
955.3
0.96
17
13
(3018418) pH of Serum or Plasma
188
1050
2.48
17.57
8.9
3.9
ph
7.4
7.4
0.22
28
191
(3047189) Immunofixation for 24 hour Urine
18
16
11.73
17.21
1.3
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
343
2581
3.18
16.48
19.7
7.6
u/l
83.3
80.4
0.67
333
2417
(40760892) CBC W Ordered Manual Differential panel - Blood
140
700
2.53
16.40
12.6
4.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
289
2011
2.54
15.95
8.6
5.0
mmol/l
7.0
6.8
0.85
271
1880
(3013707) Erythrocyte sedimentation rate by Westergren method
329
2453
2.84
15.45
7.1
4.1
mm/h
24.3
12.8
10.15
305
2237
(44790049)
23
33
7.33
15.42
1.3
1.6
—
—
—
0
0
(44806118)
23
33
7.33
15.42
1.3
1.6
—
—
—
0
0
(44790048)
23
33
7.33
15.42
1.3
1.6
—
—
—
0
0
(44790047)
23
33
7.33
15.42
1.3
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
67
235
3.22
15.24
3.1
3.9
ph
7.4
7.4
—
5
27
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
41
104
4.27
14.99
5.5
1.9
%
101.7
87.3
2.62
41
99
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
67
239
3.16
14.80
3.3
3.8
kpa
5.1
5.1
0.06
62
222
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
215
1343
2.28
14.79
3.1
2.3
nmol/l
77.3
77.5
0.03
207
1186
(3033658) Prothrombin time (PT) actual/Normal
156
853
2.35
14.71
7.5
3.9
%
84.6
87.9
0.79
151
836
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
83
337
2.84
14.57
2.6
2.3
g/l
0.2
0.2
0.25
76
317
(3048879) Bone marrow aspiration report
20
9
23.29
14.35
1.3
3.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
21
31
7.09
13.71
1.3
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
21
31
7.09
13.71
1.3
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
21
31
7.09
13.71
1.3
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
62
222
3.12
13.57
3.1
4.0
mmol/l
2.0
1.8
0.11
49
169
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
92
408
2.62
13.54
2.4
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
224
1460
2.20
13.44
25.9
9.8
e9/l
0.2
0.0
0.54
194
1196
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
22
35
6.59
13.42
1.5
1.9
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
23
39
6.19
13.20
1.5
1.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
75
305
2.79
13.05
2.0
1.9
nmol/l
345.4
384.9
1.06
70
279
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
58
5.11
13.05
1.5
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
38
101
4.05
13.04
1.7
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
91
409
2.58
12.99
2.3
1.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
183
1114
2.17
12.91
3.3
3.1
ng/l
1885.9
1451.3
0.64
160
959
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
107
3.93
12.82
2.8
2.3
u/ml
0.3
0.3
0.18
23
59
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
18
25
7.49
12.36
1.1
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
52
177
3.22
12.35
2.9
4.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
20
32
6.52
12.12
1.3
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
79
345
2.60
11.89
6.7
3.6
mmol/l
0.6
1.9
2.12
63
269
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
24
47
5.37
11.88
2.0
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
60
228
2.92
11.78
3.1
2.9
e9/l
4.4
4.0
0.45
46
172
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
48
5.25
11.61
1.5
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
24
50
5.04
11.10
1.4
1.7
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
13
14
9.56
10.82
4.7
4.4
u/l
259.8
223.9
0.58
13
14
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
62
251
2.74
10.80
5.4
3.7
ng/l
102.2
83.3
0.80
53
223
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
30
77
4.13
10.77
1.4
1.3
u/ml
2.6
1.9
—
10
13
(40765096) Chromosome analysis panel by Banding
15
8
19.41
10.33
1.4
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
13
15
8.92
10.28
1.5
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
13
15
8.92
10.28
1.5
1.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
18
8.02
10.20
1.5
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
17
28
6.29
10.00
1.2
1.2
titre
120.0
38.0
—
6
5
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
190
1257
1.97
9.96
4.7
3.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
12
13
9.48
9.92
2.2
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
13
16
8.36
9.79
1.5
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
83
404
2.33
9.77
2.4
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
185
1219
1.95
9.76
5.3
4.0
e6/l
140.2
97.7
0.32
143
886
(3002582) Erythrocytes [#/volume] in Urine
167
1065
1.97
9.68
4.7
3.4
e6/l
26.5
123.7
0.94
139
828
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
18
34
5.49
9.24
2.3
2.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
103
560
2.13
9.21
4.2
3.2
e6/l
2.2
2.5
0.18
65
304
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
27
6.13
9.19
1.3
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
155
982
1.94
9.02
4.5
3.2
e6/l
0.5
0.5
0.03
127
741
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
22
51
4.50
8.98
1.3
1.1
u/ml
2.4
1.6
—
7
15
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
47
181
2.81
8.96
7.0
3.9
mmol/l
22.9
24.1
2.25
41
168
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
20
43
4.84
8.92
1.5
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
94
499
2.15
8.91
2.9
2.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
66
302
2.42
8.89
11.0
8.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
198
1365
1.88
8.85
4.8
4.1
ng/l
32.6
40.9
0.80
159
1009
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
17
32
5.50
8.76
1.5
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
125
745
1.98
8.63
3.1
1.7
mg/l
3.3
1.4
1.27
108
576
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
22
6.56
8.58
7.8
4.0
—
—
—
0
0
(4062490)
16
29
5.70
8.56
1.9
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
52
217
2.60
8.49
2.1
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
50
205
2.64
8.45
1.4
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
105
594
2.04
8.36
3.7
2.9
e6/l
1.3
1.1
0.26
66
337
(40758292) HTLV I+II Ab panel - Serum
12
7
17.62
8.12
1.4
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
13
20
6.68
8.11
1.5
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
13
20
6.68
8.11
1.5
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
13
20
6.68
8.11
1.5
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
13
20
6.68
8.11
1.5
1.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
22
56
4.10
7.99
1.3
1.1
u/ml
2.4
3.7
—
7
26
(3032080) INR in Blood by Coagulation assay
203
1444
1.82
7.93
12.4
10.3
inr
1.5
1.3
0.83
53
408
(3037467) Urinalysis macro (dipstick) panel - Urine
288
2281
1.91
7.92
5.8
4.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
86
466
2.07
7.64
28.5
28.1
inr
1.3
1.3
—
9
59
(3015235) Bicarbonate [Moles/volume] in Capillary blood
30
100
3.16
7.36
3.1
2.3
mmol/l
24.4
24.5
0.03
25
83
(3026782) Osmolality of Urine
116
712
1.88
7.15
4.1
2.9
mosm/kgh2o
536.8
555.0
0.43
101
610
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
22
61
3.76
7.12
1.4
1.3
u/ml
60.5
46.9
—
6
6
(36304419) Bacteria [Presence] in Urine
143
942
1.80
7.00
4.1
3.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
171
1189
1.76
6.95
3.7
3.4
mmol/l
2.3
2.4
3.54
150
1027
(3000850) Epithelial cells [#/volume] in Urine
119
746
1.84
6.83
3.2
2.6
e6/l
4.7
4.9
0.08
101
666
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
17
40
4.39
6.81
2.1
1.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
6
17.05
6.77
1.0
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
64
3.58
6.66
8.8
3.6
%
53.7
59.4
0.82
22
64
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
11
9
12.52
6.62
1.5
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
33
4.68
6.51
1.1
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
27
92
3.07
6.40
1.5
1.5
iu/ml
0.0
0.1
—
6
19
(44816559) Phosphatidylethanol [Mass/volume] in Blood
20
56
3.71
6.39
1.6
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
74
404
2.02
6.38
7.1
8.5
mmol/l
0.6
1.1
0.42
56
335
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
38
4.34
6.34
1.0
1.1
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
6
0
+∞
6.26
1.2
0.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
0
+∞
6.26
1.0
0.0
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
6
0
+∞
6.26
1.0
0.0
%
9.2
—
—
6
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
6
0
+∞
6.26
1.0
0.0
%
16.5
—
—
6
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
6
0
+∞
6.26
1.0
0.0
%
32.0
—
—
6
0
(3026008) Bacteria identified in Urine by Culture
157
1091
1.72
6.24
3.7
3.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
34
136
2.64
6.04
2.0
2.3
u/l
42.5
40.0
0.23
29
122
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
22
69
3.31
5.96
1.7
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
22
69
3.31
5.96
1.7
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
31
119
2.74
5.96
2.6
3.1
—
—
—
0
0
(4268621)
16
40
4.12
5.95
2.3
2.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
365
3256
2.25
5.68
40.0
15.7
mg/l
19.5
24.8
3.81
323
2593
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
106
676
1.77
5.62
5.0
3.8
ng/l
227.2
259.6
0.11
89
558
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
34
142
2.52
5.55
3.1
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
331
2861
1.87
5.54
38.1
16.9
%
34.5
39.4
9.64
213
1965
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
5
0
+∞
5.22
1.0
0.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
8
6
13.56
5.10
2.1
1.0
%
158.0
119.8
—
8
6
(3019832) Treponema pallidum Ab [Presence] in Serum
41
194
2.24
5.09
1.6
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
9
10.19
5.05
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
9
10.19
5.05
1.0
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
67
383
1.90
5.02
2.4
2.1
ug/g
149.1
149.7
0.01
53
299
(3019225) pH of Specimen
59
324
1.96
4.97
6.4
4.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
173
1294
1.59
4.85
2.7
2.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
10
9.17
4.80
1.4
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
252
2061
1.59
4.78
4.6
3.2
u/l
57.2
48.6
0.92
237
1910
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
85
534
1.75
4.68
1.3
1.3
iu/ml
53.6
34.3
0.46
27
176
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
25
4.50
4.59
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
25
4.50
4.59
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
25
4.50
4.59
1.1
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
11
8.34
4.58
1.0
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
9
11
8.34
4.58
7.0
5.6
%
45.2
42.7
—
9
11
(3024891) Influenza virus A+B Ag [Presence] in Specimen
21
77
2.82
4.42
1.4
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
26
4.32
4.38
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
26
4.32
4.38
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
26
4.32
4.38
1.1
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
9
12
7.64
4.37
1.7
3.2
%
105.9
97.3
—
9
12
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
37
180
2.16
4.31
8.0
12.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
19
67
2.93
4.28
1.4
1.7
—
—
—
0
0
(3015736) pH of Urine
166
1257
1.54
4.27
4.4
3.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
203
1606
1.53
4.27
5.1
4.0
estimate
0.0
0.0
0.00
39
310
(3011397) Hemoglobin [Presence] in Urine by Test strip
108
741
1.62
4.24
3.7
4.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
205
1629
1.52
4.20
5.2
4.1
estimate
0.1
0.0
0.49
42
295
(3037121) Protein [Mass/volume] in Urine
26
110
2.46
4.16
3.2
3.0
g/l
0.3
0.3
0.07
13
39
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
22
86
2.65
4.12
1.4
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
10
8.13
4.08
1.5
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
7
10.15
4.02
1.0
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
43
3.34
3.94
1.4
1.1
—
—
—
0
0
(3013512) EKG study
138
1019
1.54
3.92
5.4
4.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
22
89
2.56
3.87
1.5
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
201
1613
1.49
3.80
7.1
5.4
estimate
0.0
0.0
0.00
43
303
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
5
12.15
3.77
2.2
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
5
12.15
3.77
3.7
2.8
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
5
12.15
3.77
2.2
1.0
%
82.5
91.8
—
6
5
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
36
184
2.05
3.72
6.4
2.6
%
1.6
1.1
1.40
36
184
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
330
2951
1.65
3.68
5.2
4.7
mu/l
2.0
2.4
0.42
311
2635
(3019550) Sodium [Moles/volume] in Serum or Plasma
364
3346
1.89
3.64
39.5
18.5
mmol/l
139.4
139.6
0.99
357
3249
(3003327) Ova and parasites identified in Stool by Light microscopy
21
87
2.49
3.53
1.4
1.6
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
6
10.12
3.50
1.3
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
6
10.12
3.50
1.0
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
280
2424
1.51
3.50
4.1
3.9
pmol/l
14.8
14.9
0.25
260
2151
(3023103) Potassium [Moles/volume] in Serum or Plasma
364
3355
1.86
3.48
41.5
18.7
mmol/l
4.0
4.0
2.08
355
3253
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
104
740
1.55
3.43
1.6
1.8
pmol/l
475.5
442.8
0.43
88
594
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
37
197
1.97
3.43
2.5
2.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
35
183
2.00
3.41
1.2
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
76
503
1.63
3.40
1.2
1.3
u/ml
17.7
13.5
0.11
17
191
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
18
5.09
3.39
1.9
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
18
5.09
3.39
1.9
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
23
102
2.33
3.36
3.9
3.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
14
5.80
3.35
1.1
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
98
693
1.55
3.32
1.4
1.2
u/ml
2.9
1.9
0.16
28
195
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
137
1040
1.48
3.31
2.0
2.1
u/l
123.0
260.2
1.20
129
972
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
97
688
1.54
3.23
3.7
3.2
mmol/l
2.4
2.5
0.81
88
604
(4281824)
11
33
3.40
3.21
1.2
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
55
2.79
3.19
1.3
1.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
9
20
4.58
3.13
1.0
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
368
3424
1.84
3.11
25.6
10.8
u/l
25.9
25.5
0.21
360
3284
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
27
133
2.10
3.09
2.7
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
34
3.30
3.08
1.4
2.5
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
5
10.10
2.98
1.2
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
112
832
1.48
2.98
1.6
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
62
404
1.63
2.95
1.5
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
41
241
1.78
2.83
4.0
6.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
17
72
2.42
2.76
1.2
1.3
miu/ml
358.3
216.9
—
6
32
(3009871) Measles virus Ab [Titer] in Serum
5
6
8.42
2.75
1.8
1.7
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
9
24
3.81
2.68
1.1
1.2
—
94.4
—
0
5
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
32
3.18
2.66
1.7
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
128
994
1.42
2.66
3.6
3.2
mg/l
3987.0
185.1
2.46
93
641
(21494755) Public health laboratory ask at order entry panel
9
225
0.39
2.64
1.2
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
14
56
2.55
2.56
2.8
3.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
13
50
2.65
2.55
1.3
2.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
10
33
3.08
2.54
1.4
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
18
82
2.25
2.51
9.7
2.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
15
63
2.43
2.49
4.2
3.0
—
—
—
0
0
(3036603) Volume of Urine
8
21
3.86
2.47
1.1
1.7
—
1836.0
—
0
5
(3028626) Oxygen [Partial pressure] in Capillary blood
21
103
2.10
2.46
2.9
3.3
kpa
7.9
8.2
0.21
15
93
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
60
407
1.56
2.43
3.9
4.3
ug/l
3.4
40.1
1.15
55
343
(40768797) Stomach Pathology biopsy report
66
458
1.53
2.41
1.3
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
12
5.06
2.41
2.7
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
36
215
1.74
2.38
12.5
6.6
mmol/l
23.1
24.7
1.86
36
215
(3045424) Erythrocytes [Presence] in Urine
13
52
2.55
2.38
1.5
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
41
256
1.67
2.32
3.9
2.9
ml/min/173m2
49.9
62.1
1.51
21
105
(3029937) Albumin [Presence] in Urine by Test strip
114
892
1.39
2.22
5.7
4.3
estimate
0.0
0.0
0.50
41
301
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
30
3.04
2.16
2.6
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
326
3009
1.43
2.15
34.2
14.9
ml/min/173m2
74.6
77.1
1.10
292
2477
(3020682) Albumin/Creatinine [Ratio] in Urine
131
1056
1.36
2.11
5.1
4.0
mg/mmol
13.8
9.0
0.67
89
662
(3009508) Creatinine [Moles/volume] in Urine
130
1047
1.36
2.11
3.5
3.1
mmol/l
6.6
7.3
1.18
111
858
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
31
2.95
2.08
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
15
69
2.22
2.07
2.7
2.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
29
170
1.76
2.06
1.3
1.2
u/ml
319.6
173.0
0.44
19
155
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
15
4.04
2.04
1.0
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
24
133
1.86
2.04
1.6
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
63
2.27
2.03
1.8
1.5
—
—
—
0
0
(4306422)
11
44
2.54
2.03
1.2
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
38
2.67
2.02
1.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
21
3.37
1.97
1.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
21
3.37
1.97
1.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
51
2.39
1.97
1.2
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
11
4.59
1.94
1.4
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
27
3.00
1.94
2.8
1.9
%
10.1
10.7
—
8
27
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
16
3.79
1.94
2.2
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
16
3.79
1.94
1.7
1.6
g/l
1.0
1.0
—
6
16
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
16
3.79
1.94
2.2
1.4
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
6
17
3.57
1.84
1.2
1.1
u/l
120.5
103.6
—
6
11
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
209
1829
1.30
1.82
3.1
2.8
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
47
2.38
1.79
1.8
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
47
2.38
1.79
1.8
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
67
2.13
1.78
4.6
2.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
14
67
2.13
1.78
3.1
2.7
%
16.2
15.4
—
8
32
(3020891) Body temperature
23
133
1.77
1.74
6.6
3.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
24
2.95
1.73
1.3
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
13
3.88
1.72
7.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
48
2.33
1.72
1.8
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
48
2.33
1.72
1.8
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
48
2.33
1.72
1.8
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
48
2.33
1.72
1.8
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
12
55
2.22
1.69
1.4
1.4
g/l
26.1
32.1
0.65
12
46
(4024509)
7
25
2.83
1.65
1.0
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
25
2.83
1.65
2.3
1.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
92
728
1.34
1.65
5.0
4.3
kg/l
1.0
1.0
0.29
15
105
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
14
3.60
1.62
1.0
1.2
iu/ml
98.6
175.7
—
5
14
(3007461) Platelets [#/volume] in Blood
370
3541
1.53
1.60
62.3
22.9
e9/l
232.5
245.5
2.14
362
3454
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
20
3.03
1.58
2.5
2.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
20
3.03
1.58
2.5
2.0
—
—
—
0
0
(3035941) MCH [Entitic mass]
370
3543
1.53
1.57
61.7
22.8
pg
31.4
30.3
11.31
365
3485
(40761511) CBC panel - Blood by Automated count
353
3351
1.42
1.57
36.4
14.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
28
177
1.63
1.56
7.2
4.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
370
3544
1.52
1.56
61.8
22.8
fl
94.6
91.3
16.65
365
3487
(3026361) Erythrocytes [#/volume] in Blood
370
3544
1.52
1.56
62.0
22.9
e12/l
3.9
4.5
34.41
362
3441
(3010813) Leukocytes [#/volume] in Blood
370
3545
1.52
1.54
62.1
22.9
e9/l
8.8
6.8
2.02
362
3442
(40768806) Pleura Pathology biopsy report
10
44
2.31
1.54
1.3
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
56
414
1.41
1.52
1.4
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
148
1262
1.27
1.52
6.0
4.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
21
2.88
1.51
1.3
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
45
2.25
1.47
1.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
38
2.40
1.46
1.4
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
95
1.82
1.45
1.4
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
103
1.78
1.43
1.4
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
11
53
2.11
1.39
1.2
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
41
2.22
1.38
1.1
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
17
2.96
1.36
1.0
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
12
61
2.00
1.34
12.8
2.5
%
64.6
60.5
0.19
12
61
(3035285) Chloride [Moles/volume] in Venous blood
11
54
2.07
1.34
1.9
2.8
mmol/l
103.9
105.7
0.63
11
54
(3041354) Potassium [Moles/volume] in Venous blood
11
54
2.07
1.34
1.9
2.8
mmol/l
4.0
4.1
0.11
11
54
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
54
2.07
1.34
1.9
2.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
17
98
1.77
1.33
1.2
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
8
34
2.38
1.30
1.0
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
5
18
2.80
1.29
3.6
2.9
—
31.8
—
0
5
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
10
48
2.11
1.28
10.1
6.4
mg/l
14.8
11.9
—
10
43
(3022806) Fractional oxyhemoglobin in Capillary blood
9
44
2.07
1.27
1.8
1.9
%
89.6
89.3
—
9
44
(3003740) Influenza virus B Ag [Presence] in Specimen
8
35
2.31
1.27
1.5
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
35
2.31
1.27
1.5
1.1
—
—
—
0
0
(1002224) Polysomnography panel
5
115
0.43
1.27
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
25
163
1.57
1.26
1.2
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
87
1049
0.78
1.23
3.4
3.0
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
21
132
1.62
1.23
2.9
2.1
ug/l
667.4
567.9
0.06
21
125
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
103
1.68
1.14
1.5
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
19
119
1.63
1.14
1.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
21
2.40
1.09
3.6
2.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
41
1.97
1.09
5.9
3.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
74
1.78
1.08
7.2
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
17
105
1.65
1.08
1.5
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
39
290
1.38
1.06
3.6
3.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
53
414
1.32
1.06
12.5
7.6
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
33
2.14
1.06
2.1
2.4
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
13
75
1.76
1.04
5.8
3.2
kpa
4.7
4.9
0.91
13
75
(3012501) Base excess in Blood by calculation
13
75
1.76
1.04
5.8
3.2
mmol/l
2.5
2.5
—
8
52
(3027315) Oxygen [Partial pressure] in Blood
13
75
1.76
1.04
5.8
3.2
kpa
7.9
8.2
0.27
13
75
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
34
2.08
1.03
1.9
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
47
1.94
1.02
1.1
1.1
—
—
—
0
0
(4146454)
7
35
2.02
1.00
2.1
2.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
50
1.82
0.97
1.3
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
37
1.91
0.94
2.6
4.9
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
23
159
1.47
0.93
2.9
2.9
u/ml
19.5
62.6
1.05
23
153
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
18
118
1.55
0.92
1.8
1.6
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
6
29
2.08
0.89
1.2
1.3
nmol/l
0.3
0.4
—
6
21
(3022145) Colonoscopy Study observation
49
389
1.30
0.89
1.6
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
30
2.01
0.87
1.2
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
72
1.69
0.86
2.6
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
16
104
1.56
0.86
1.7
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
22
155
1.44
0.83
1.5
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
30
224
1.37
0.82
3.6
2.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
47
1.72
0.81
1.4
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
33
1.83
0.79
1.3
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
33
1.83
0.79
1.3
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
26
0.00
0.78
0.0
1.1
—
1.4
—
0
5
(1761482) Bacteria [#/volume] in Urine by Culture
16
108
1.50
0.74
6.6
5.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
5
25
2.01
0.73
1.0
1.2
%
51.9
29.6
—
5
18
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
5
25
2.01
0.73
1.2
1.5
u/l
—
7.4
—
0
11
(3025130) Human papilloma virus identified in Specimen
5
25
2.01
0.73
3.2
2.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
14
205
0.67
0.72
1.3
1.9
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
26
1.93
0.71
1.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
27
1.86
0.68
14.0
2.4
%
14.8
13.3
—
5
27
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
326
3145
1.19
0.68
5.0
4.8
mmol/l
6.2
6.0
0.83
303
2838
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
81
924
0.85
0.66
3.8
4.6
%
24.9
21.6
1.20
41
470
(3044889) 12 lead EKG panel
246
2327
1.15
0.66
4.6
4.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
29
1.73
0.64
3.4
3.0
—
—
—
0
0
(3010421) pH of Blood
13
88
1.49
0.61
6.1
3.1
ph
7.4
7.4
0.03
13
75
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
24
309
0.76
0.60
2.0
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
22
0.00
0.59
0.0
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
47
394
1.22
0.58
1.7
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
36
1.68
0.57
1.3
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
36
1.68
0.57
2.0
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
100
899
1.15
0.56
6.3
3.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
42
351
1.22
0.54
6.0
3.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
58
668
0.85
0.54
2.8
3.1
ug/l
1.3
0.8
0.98
43
454
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
6
39
1.55
0.53
1.3
1.4
nmol/l
0.5
0.6
—
6
34
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
17
224
0.75
0.51
1.4
2.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
13
94
1.40
0.46
2.2
2.5
ug/min
121.3
77.9
—
6
54
(40768800) Prostate Pathology biopsy report
5
83
0.60
0.46
1.2
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
304
3128
0.89
0.46
5.1
4.6
mmol/l
1.4
1.5
2.11
283
2834
(3035637) Corticotropin [Mass/volume] in Plasma
5
31
1.62
0.43
1.2
1.5
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
15
0.00
0.41
0.0
1.1
—
7.6
—
0
15
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
34
1.48
0.40
1.4
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.1
—
1.0
—
0
13
(3001019) Free T4 and TSH panel - Serum or Plasma
7
103
0.67
0.40
2.1
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
71
1.42
0.39
1.8
2.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
36
1.39
0.38
1.4
2.2
umol/l
47.0
4.3
—
5
27
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
315
3222
0.90
0.36
5.5
5.2
mmol/l
2.5
2.7
3.74
294
2921
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
14
179
0.77
0.36
1.4
1.2
iu/ml
22.1
173.3
—
8
72
(3049717) Cytology report of Urine Cyto stain
18
144
1.26
0.36
3.6
2.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
24
199
1.22
0.36
1.3
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
73
1.38
0.35
1.6
1.3
—
—
—
0
0
(3000492) Spirometry study
23
275
0.83
0.34
1.8
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
47
419
1.14
0.32
4.7
4.7
%
30.7
32.1
0.28
33
264
(3008898) HLA-B27 [Presence]
7
96
0.72
0.31
1.1
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
38
1.32
0.23
1.8
2.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
38
1.32
0.23
1.0
2.5
nmol/l
10.5
7.1
—
5
38
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
305
2995
1.07
0.23
7.0
6.2
mmol/mol
37.8
40.5
3.70
279
2758
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
5
40
1.25
0.22
1.2
1.1
—
26.3
—
0
8
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
20
172
1.17
0.22
1.3
1.4
—
54.1
—
0
12
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
297
3022
0.94
0.21
4.8
4.1
mmol/l
1.4
1.3
1.35
274
2717
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.1
—
0.7
—
0
5
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
15.1
—
849.0
—
0
13
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
311
3155
0.94
0.19
5.1
4.6
mmol/l
4.3
4.6
3.22
290
2881
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
44
475
0.92
0.18
1.6
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
62
1.13
0.17
1.0
1.7
—
—
—
0
0
(4010399)
27
249
1.09
0.12
1.2
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
22
238
0.92
0.10
2.2
2.1
nmol/l
12.9
13.3
0.07
17
214
(40761536) Microorganisms panel - Urine sediment
29
272
1.07
0.09
7.5
4.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
118
1153
1.03
0.09
4.1
5.3
ug/l
2.5
2.6
0.07
104
1019
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
20
216
0.92
0.08
1.6
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
58
1.04
0.08
2.2
2.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
5
64
0.78
0.08
2.2
2.7
u/ml
39.6
32.5
—
5
64
(4094501)
8
76
1.05
0.07
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
112
0.89
0.07
1.4
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
80
0.87
0.07
1.1
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
91
0.88
0.07
1.0
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
24
226
1.07
0.06
1.5
1.4
—
—
—
0
0
(4034850)
9
105
0.85
0.06
11.9
10.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
141
0.99
0.00
1.2
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
86
858
1.00
0.00
1.6
1.6
mmol/l
1.6
1.3
1.43
74
712
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
157
1.02
0.00
1.0
1.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
11
105
1.05
0.00
1.5
1.9
mg/l
7.2
4.4
—
6
78
(3000764) Benzodiazepines [Presence] in Urine
7
78
0.90
0.00
1.1
1.5
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
9.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
9.7
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
9.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
18.0
—
0
7
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
559.4
—
0
5
(36660697) Celiac disease serology panel - Serum
23
230
1.00
0.00
1.1
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
57
0.88
0.00
1.6
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
79
0.88
0.00
1.6
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
1.8
—
0
6
(3021387) Prolactin [Units/volume] in Serum or Plasma
6
67
0.89
0.00
1.3
1.5
mu/l
242.3
343.7
—
6
60
(3028300) Cannabinoids [Presence] in Urine
7
79
0.88
0.00
1.1
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
56
0.89
0.00
1.4
2.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
42.7
—
0
7
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
73
0.96
0.00
1.1
1.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
79
0.88
0.00
1.1
1.5
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
2.0
—
0
7
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
77.4
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint D3_AIHA_OTHER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_AIHA_OTHER | 2.299 [1.91, 2.77] | < 0.001 |
| Birth year | 1.0 [0.99, 1.01] | 0.982 |
During the follow-up period (1.1.1998 — 31.12.2019), 489 out of 1170 females with D3_AIHA_OTHER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_AIHA_OTHER | 2.82 [2.2, 3.62] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 421 out of 976 males with D3_AIHA_OTHER died.
Mortality risk
Mortality risk for people of age
years, who have D3_AIHA_OTHER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.296% | 0.505% |
| 5 | 1.48% | 3.21% |
| 10 | 3.848% | 8.18% |
| 15 | 7.384% | 13.968% |
| 20 | 13.26% | 22.862% |
Relationships between endpoints
↥Index endpoint: D3_AIHA_OTHER – Other autoimmune haemolytic anaemias
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data